Breast Cancer Overview
Breast Cancer Overview
Breast cancer is a type of cancer that originates in the cells of the breast. It is one of the most common cancers among women worldwide, though it can also occur in men.
Anatomy of the Breast
Understanding the normal anatomy of the breast helps in understanding where cancer can arise:
- Lobules: These are the milk-producing glands of the breast.
- Ducts: These are tubes that carry milk from the lobules to the nipple. Most breast cancers begin in the ducts.
- Connective Tissue: Includes fibrous tissue and fatty tissue that surround the lobules and ducts, giving the breast its shape.
- Blood Vessels and Lymphatic Vessels: The breast has a rich blood supply and a network of lymphatic vessels and lymph nodes. Lymph nodes are small, bean-shaped glands part of the body's immune system. Breast cancer cells can travel through these lymphatic vessels and spread to nearby lymph nodes, most commonly in the armpit (axillary lymph nodes).
Pathology and Types of Breast Cancer
Breast cancer is characterized by the uncontrolled growth of abnormal cells. Pathologists examine tissue samples (biopsies) under a microscope to determine the type of cancer and its characteristics.
Main Types:
Ductal Carcinoma:
- Ductal Carcinoma In Situ (DCIS): Considered "stage 0" or non-invasive breast cancer. Cancer cells are present only in the lining of the milk ducts and have not spread into surrounding breast tissue. While not immediately life-threatening, it can become invasive if left untreated.
- Invasive Ductal Carcinoma (IDC): The most common type (about 70-80% of cases). It starts in the milk ducts but has broken through duct walls and invaded surrounding fatty breast tissue. It can spread to other parts of the body.
Lobular Carcinoma:
- Lobular Carcinoma In Situ (LCIS): Not a true cancer but a marker for increased risk of developing invasive breast cancer. Cells grow abnormally within lobules but have not spread.
- Invasive Lobular Carcinoma (ILC): The second most common type (10-15%). Starts in lobules and spreads into surrounding tissue. Harder to detect on mammograms as it grows diffusely rather than forming lumps.
Less Common and Special Types:
- Inflammatory Breast Cancer (IBC): Rare but aggressive, cancer cells block lymph vessels in the skin causing redness, swelling, warmth, and skin dimpling (orange peel texture). Often no lump.
- Paget's Disease of the Nipple: Rare cancer involving nipple and areola skin, often linked to underlying DCIS or invasive cancer.
- Triple-Negative Breast Cancer (TNBC): Aggressive type testing negative for estrogen receptors (ER-), progesterone receptors (PR-), and HER2 protein; less responsive to hormone or HER2 therapies.
- HER2-Positive Breast Cancer: Cancer cells have excess HER2 protein, grow and spread faster, but respond well to targeted HER2 therapies.
- Hormone Receptor-Positive Breast Cancer (ER+/PR+): Cancers fueled by estrogen and/or progesterone hormones and usually respond well to hormone therapy.
Symptoms
While breast cancer can sometimes be asymptomatic, common signs and symptoms include:
- A new lump or mass in the breast or underarm (armpit) - most common symptom.
- Change in size or shape of the breast.
- Dimpling of the skin (orange peel appearance).
- Redness or flaky skin on the nipple or breast.
- Pulling in of the nipple or nipple discharge other than breast milk (especially if bloody).
- Breast or nipple pain that doesn't go away.
Note: Many breast changes are benign, but any new or unusual symptom should be evaluated by a doctor.
Risk Factors
Risk factors increase the likelihood of breast cancer but don't guarantee it:
- Gender: Being female is the biggest risk factor.
- Age: Risk increases especially after 50 years old.
- Genetics: Inherited mutations (e.g., BRCA1/BRCA2) and family history of breast or ovarian cancer.
- Reproductive History: Early menstruation, late menopause, no full-term pregnancy, or first pregnancy after age 30.
- Breast Density: Dense breasts complicate mammograms and increase risk.
- Personal History: Previous breast cancer increases risk in the other breast.
- Radiation Exposure: Chest radiation at young age.
- Hormone Therapy: Combined estrogen-progestin therapy after menopause.
- Obesity: Particularly after menopause.
- Alcohol Consumption: Higher intake increases risk.
- Lack of Physical Activity.
Diagnosis
Common diagnostic methods include:
- Clinical Breast Exam (CBE): Physical examination by a doctor.
- Mammogram: X-ray of the breast for screening and diagnosis.
- Breast Ultrasound: Sound waves create images, used to evaluate abnormalities.
- Breast MRI: Uses magnets and radio waves, often for high-risk or detailed evaluation.
- Biopsy: Tissue sample removal for microscopic examination to confirm cancer type.
Staging
Staging determines cancer size, lymph node involvement, and distant spread, guiding treatment and prognosis. The TNM system is common:
- Stage 0: DCIS (non-invasive).
- Stages I-III: Invasive cancer localized or with nearby lymph node spread.
- Stage IV: Metastatic cancer spread to distant organs (bones, lungs, liver, brain).
Treatment
Treatment depends on cancer type, stage, hormone receptor and HER2 status, and patient health. Common treatments include:
- Surgery: Lumpectomy, mastectomy, lymph node dissection.
- Radiation Therapy: High-energy rays to kill cancer cells.
- Chemotherapy: Drugs to kill cancer cells systemically.
- Hormone Therapy: For hormone receptor-positive cancers.
- Targeted Therapy: Drugs targeting specific cancer cell features (e.g., HER2).
- Immunotherapy: Boosts immune system to fight cancer.
Prognosis and Survival Rates
Prognosis depends on stage, cancer type, and treatment response. Early localized breast cancer has a high survival rate. Advances in detection and treatment have improved outcomes greatly.
Breast Cancer in Jordan
According to the 2017 Cancer Incidence report in Jordan:
- Breast cancer is the most common cancer among Jordanians (males and females combined).
- Out of 6352 cancer cases, 1302 (20.5%) were breast cancer.
- It is the most common cancer diagnosis among Jordanian females.
- Breast cancer is the leading cause of cancer death among females in Jordan (22%).
This underscores the need for awareness, screening, and treatment programs in Jordan.